News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
278,378 Results
Type
Article (14473)
Company Profile (101)
Press Release (263802)
Multimedia
Podcasts (71)
Webinars (14)
Section
Business (88531)
Career Advice (468)
Deals (15473)
Drug Delivery (82)
Drug Development (36787)
Employer Resources (50)
FDA (6417)
Job Trends (6246)
News (151128)
Policy (14168)
Tag
2027 BioCapital Standard (1)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (1)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (452)
Accelerated approval (25)
ADA (10)
Adcomms (9)
Allergies (98)
Alliances (23355)
ALS (72)
Alzheimer's disease (522)
Antibody-drug conjugate (ADC) (161)
Approvals (6720)
Artificial intelligence (267)
ASCO (113)
Autoimmune disease (78)
Automation (20)
Bankruptcy (151)
Best Places to Work (4370)
BIOSECURE Act (9)
Biosimilars (152)
Biotechnology (39)
Bladder cancer (51)
Brain cancer (40)
Breast cancer (210)
Cancer (1722)
Cardiovascular disease (201)
Career advice (421)
Career pathing (14)
CAR-T (66)
CDC (7)
Cell therapy (199)
Cervical cancer (20)
Clinical research (32596)
Collaboration (943)
Commercialization (1)
Company closure (1)
Compensation (396)
Complete response letters (46)
COVID-19 (786)
CRISPR (53)
C-suite (635)
Cystic fibrosis (61)
Data (2539)
Decentralized trials (1)
Denatured (19)
Depression (59)
Dermatology (15)
Diabetes (167)
Diagnostics (1457)
Digital health (16)
Diversity (2)
Diversity, equity & inclusion (14)
Drug discovery (159)
Drug pricing (122)
Drug shortages (15)
Duchenne muscular dystrophy (99)
Earnings (34314)
Editorial (24)
Employer branding (4)
Employer resources (46)
Events (39951)
Executive appointments (610)
FDA (7808)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (2)
Frontotemporal dementia (4)
Funding (545)
Gene editing (85)
Generative AI (27)
Gene therapy (202)
GLP-1 (491)
Government (1431)
Grass and pollen (4)
Guidances (173)
Healthcare (3647)
Hematology (66)
HIV (17)
Huntington's disease (12)
IgA nephropathy (52)
Immunology and inflammation (83)
Immuno-oncology (30)
Indications (95)
Infectious disease (883)
Inflammatory bowel disease (86)
Inflation Reduction Act (7)
Influenza (28)
Intellectual property (138)
Interviews (60)
IPO (5936)
IRA (33)
Job creations (2060)
Job search strategy (374)
JPM (29)
Kidney cancer (12)
Labor market (35)
Layoffs (210)
Leadership (10)
Legal (3459)
Liver cancer (27)
Longevity (10)
Lung cancer (237)
Lymphoma (156)
Machine learning (14)
Management (17)
Manufacturing (558)
Marketing (1)
MASH (90)
Medical affairs (1)
Medical device (1319)
Medtech (1334)
Mergers & acquisitions (10056)
Metabolic disorders (567)
mRNA (63)
Multiple sclerosis (59)
NASH (15)
Neurodegenerative disease (109)
Neuropsychiatric disorders (48)
Neuroscience (1055)
Neurotech (1)
NextGen: Class of 2026 (1592)
Non-profit (608)
Now hiring (23)
Obesity (291)
Opinion (151)
Ovarian cancer (65)
Pain (136)
Pancreatic cancer (71)
Parkinson's disease (110)
Partnered (12)
Patents (277)
Patient recruitment (172)
Peanut (15)
People (30237)
Pharmaceutical (60)
Pharmacy benefit managers (19)
Phase 1 (8448)
Phase 2 (13769)
Phase 3 (12434)
Pipeline (3468)
Policy (148)
Postmarket research (1403)
Preclinical (3409)
Press Release (25)
Prostate cancer (113)
Psychedelics (22)
Radiopharmaceuticals (158)
Rare diseases (468)
Real estate (2681)
Recruiting (19)
Regulatory (11406)
Reports (16)
Research institute (582)
Resumes & cover letters (56)
Rett syndrome (11)
RNA editing (9)
RSV (24)
Schizophrenia (87)
Series A (111)
Series B (63)
Service/supplier (2)
Sickle cell disease (55)
Special edition (11)
Spinal muscular atrophy (85)
Sponsored (11)
Startups (1653)
State (2)
Stomach cancer (6)
Supply chain (64)
Tariffs (71)
The Weekly (50)
Vaccines (272)
Venture capital (39)
Weight loss (172)
Women's health (50)
Worklife (4)
Date
Today (35)
Last 7 days (204)
Last 30 days (935)
Last 365 days (10366)
2026 (5135)
2025 (10711)
2024 (12502)
2023 (14257)
2022 (19577)
2021 (20086)
2020 (19054)
2019 (14912)
2018 (11738)
2017 (13924)
2016 (13170)
2015 (15510)
2014 (12448)
2013 (10608)
2012 (11418)
2011 (11963)
2010 (10906)
Location
Africa (323)
Alabama (20)
Alaska (1)
Arizona (89)
Arkansas (4)
Asia (21539)
Australia (2739)
California (3917)
Canada (1784)
China (745)
Colorado (173)
Connecticut (155)
Delaware (167)
Europe (41663)
Florida (743)
Georgia (78)
Hawaii (1)
Idaho (11)
Illinois (455)
India (65)
Indiana (306)
Iowa (2)
Japan (346)
Kansas (84)
Kentucky (21)
Louisiana (7)
Maine (2)
Maryland (500)
Massachusetts (3170)
Michigan (54)
Minnesota (205)
Mississippi (1)
Missouri (38)
Montana (9)
Nebraska (8)
Nevada (19)
New Hampshire (9)
New Jersey (1748)
New Mexico (7)
New York (1127)
North Carolina (739)
North Dakota (2)
Northern California (1854)
Ohio (94)
Oklahoma (5)
Oregon (18)
Pennsylvania (853)
Puerto Rico (18)
Rhode Island (18)
South America (508)
South Carolina (11)
Southern California (1722)
Tennessee (66)
Texas (560)
United States (15562)
Utah (65)
Virginia (208)
Washington D.C. (42)
Washington State (287)
West Virginia (1)
Wisconsin (50)
Wyoming (1)
278,378 Results for "shandong luoxin pharmaceutical".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Univar Solutions and Shandong Head Group Co., Ltd. Establish Exclusive European Partnership to Enhance Supply of Cellulose Ethers and Pharmaceutical Excipients
May 22, 2025
·
7 min read
Luoxin Pharmaceutical signs licensing agreement with Austria-based Marinomed Biotech AG for Budesolv® Budesonide Nasal Spray
Shandong Luoxin Pharmaceutical Group Stock Co., Ltd., a subsidiary of Luoxin Pharmaceutical Group Stock Co., Ltd., signed a licensing agreement with Austria-based Marinomed Biotech AG, whereby Shandong Luoxin will gain the exclusive rights for the development, manufacture, and commercialization of Budesolv® in China.
October 21, 2021
·
4 min read
Press Releases
Corvus Pharmaceuticals Announces Additional Investment in Angel Pharmaceuticals to Advance the Development of Soquelitinib in China
June 9, 2026
·
9 min read
BioMidwest
Guided Therapeutics Announces New Agreement and Purchase Orders from Shandong Yaohua Medical Instrument Corporation
Guided Therapeutics, Inc. announced that it had signed a new agreement with the Company’s Chinese co-manufacturing partner and distributor for China, Shandong Yaohua Medical Instrument Corporation.
March 15, 2023
·
4 min read
Business
Synergy Pharmaceuticals Announces License Agreement with Luoxin Pharmaceutical Group for TRULANCE® (plecanatide) in China
Synergy Pharmaceuticals Inc. announced that the company has entered into a license agreement with Luoxin Pharmaceutical Group Co., Ltd., Shandong (Luoxin) providing Luoxin exclusive rights to develop and commercialize Synergy’s lead product TRULANCE® (plecanatide)
August 7, 2018
·
6 min read
Press Releases
Insilico Medicine Launches Science MMAI Gym to Transform Frontier LLMs into Pharmaceutical-Grade Scientific Engines
January 22, 2026
·
1 min read
Press Releases
Faron Pharmaceuticals Ltd: Registration of Treasury Shares
June 11, 2026
·
2 min read
Press Releases
X4 Pharmaceuticals to Present at the 2026 Jefferies Global Healthcare Conference
May 27, 2026
·
1 min read
Press Releases
Reacta Healthcare Receives Extended MHRA Pharmaceutical Manufacturer’s Licence and GMP Certificate
June 10, 2026
·
2 min read
Press Releases
Chiesi Group Completes Acquisition of KalVista Pharmaceuticals
June 11, 2026
·
8 min read
1 of 27,838
Next
